DUBLIN--(BUSINESS WIRE)--The "Superdisintegrants Market Analysis by Product (Croscarmellose sodium, Crospovidone, Sodium starch glycolate, Ion exchange resin), by Dosage Form (Tablets and Capsules, Mouth-dissolving Films) and Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.
The global superdisintegrants market is expected to reach USD 487.0 million by 2025
Superdisintegrants help in the disintegration of tablet or capsule content into small particles and create a greater surface area for speedy drug release.
A number of fast disintegrating tablet such as salbutamol sulphate, and cetirizine hydrochloride in tablet/capsule dosage form for respiratory disorders (bronchitis, asthma, and coughing) are formulated for pediatric and geriatric patients, due to their difficulty or discomfort in swallowing. Superdisintegrant such as crospovidone, croscarmellose sodium, and sodium starch glycolate are used in optimized concentration to formulate such tablets/capsules along with different binders such as MCC and PVP K-30.
Some of the major companies operating in this market are Ashland Global Holdings Inc., Roquette Frres S.A., FMC Corporation, DFE Pharma, Huber Corporation, Nippon Soda Co., Ltd. The Dow Chemical Company and BASF SE. and others.
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Superdisintegrants Market Variables, Trends & Scope
Chapter 4 Superdisintegrants Market: Product Estimates & Trend Analysis
Chapter 5 Superdisintegrants Market: Dosage Form Estimates & Trend Analysis
Chapter 6 Superdisintegrants Market: Regional Estimates & Trend Analysis, by Product & Dosage Form
Chapter 7 Competitive Landscape
- Ashland Global Holdings Inc.
- BASF SE
- Company Profiles
- DFE Pharma
- FMC Corporation
- Huber Corporation
- Nippon Soda Co., Ltd.
- Roquette Frres S.A.
- Strategy Framework
- The Dow Chemical Company
For more information about this report visit https://www.researchandmarkets.com/research/sk3s22/superdisintegrants
